1. The role of adjuvant therapy for breast cancer

   Newsletter Article 25 February 2013 Pages: 2 - 2

2. Adverse effects of H2-antagonists

   Newsletter Article 25 February 2013 Pages: 3 - 3

3. Assessing quality of life during antihypertensive therapy

   Newsletter Article 25 February 2013 Pages: 3 - 3

4. Aluminium hydroxide

   Newsletter Article 25 February 2013 Pages: 4 - 4

5. Aminoglycosides

   Newsletter Article 25 February 2013 Pages: 4 - 4

6. Amiodarone

   Newsletter Article 25 February 2013 Pages: 4 - 4

7. Amphotericin B

   Newsletter Article 25 February 2013 Pages: 4 - 4

8. Analgesics

   Newsletter Article 25 February 2013 Pages: 4 - 4

9. Analgesics/anti-inflammatories, non-steroidal

   Newsletter Article 25 February 2013 Pages: 4 - 4

10. Anti-inflammatories, non-steroidal see Analgesics/anti-inflammatories, non-steroidal

    Newsletter Article 25 February 2013 Pages: 4 - 4

11. Antineoplastics

    Newsletter Article 25 February 2013 Pages: 4 - 5

12. Antipsychotics

    Newsletter Article 25 February 2013 Pages: 5 - 5

13. Bendroflumethiazide see Enalapril interaction

    Newsletter Article 25 February 2013 Pages: 5 - 5

14. Benzodiazepine interaction

    Newsletter Article 25 February 2013 Pages: 5 - 5

15. Beta-blockers

    Newsletter Article 25 February 2013 Pages: 5 - 5

16. Carbamazepine interaction

    Newsletter Article 25 February 2013 Pages: 5 - 5

17. Chloroquine

    Newsletter Article 25 February 2013 Pages: 5 - 6

18. Chlorprothixene overdose

    Newsletter Article 25 February 2013 Pages: 6 - 6

19. Cimetidine see Benzodiazepine interaction

    Newsletter Article 25 February 2013 Pages: 6 - 6

20. Cocaine abuse

    Newsletter Article 25 February 2013 Pages: 6 - 6

21. Cotrimoxazole

    Newsletter Article 25 February 2013 Pages: 6 - 6

22. Cyclosporin

    Newsletter Article 25 February 2013 Pages: 6 - 7

23. Cytarabine

    Newsletter Article 25 February 2013 Pages: 7 - 7

24. Dextran

    Newsletter Article 25 February 2013 Pages: 7 - 7

25. Diethylstilbestrol

    Newsletter Article 25 February 2013 Pages: 7 - 7

26. Doxorubicin

    Newsletter Article 25 February 2013 Pages: 7 - 7

27. Doxycycline

    Newsletter Article 25 February 2013 Pages: 7 - 7

28. Enalapril interaction

    Newsletter Article 25 February 2013 Pages: 7 - 7

29. Erythromycin see Benzodiazepine interaction

    Newsletter Article 25 February 2013 Pages: 7 - 7

30. Indomethacin

    Newsletter Article 25 February 2013 Pages: 7 - 7

31. Inosine pranobex

    Newsletter Article 25 February 2013 Pages: 7 - 8

32. Heparin

    Newsletter Article 25 February 2013 Pages: 8 - 8

33. Hydrochlorothiazide

    Newsletter Article 25 February 2013 Pages: 8 - 8

34. Hydroquinidine/quinidine

    Newsletter Article 25 February 2013 Pages: 8 - 8

35. Josamycin see Benzodiazepine interaction

    Newsletter Article 25 February 2013 Pages: 8 - 8

36. Ketoprofen

    Newsletter Article 25 February 2013 Pages: 8 - 8

37. Lidocaine

    Newsletter Article 25 February 2013 Pages: 8 - 8

38. Lithium

    Newsletter Article 25 February 2013 Pages: 8 - 8

39. LM 985

    Newsletter Article 25 February 2013 Pages: 8 - 8

40. Meclofenamic acid

    Newsletter Article 25 February 2013 Pages: 8 - 8

41. Mefenamic acid overdose

    Newsletter Article 25 February 2013 Pages: 9 - 9

42. Paracetamol

    Newsletter Article 25 February 2013 Pages: 9 - 9

43. Phenytoin

    Newsletter Article 25 February 2013 Pages: 9 - 9

44. Praziquantel

    Newsletter Article 25 February 2013 Pages: 9 - 9

45. Quinidine see Hydroquinidine/quinidine

    Newsletter Article 25 February 2013 Pages: 9 - 9

46. Quinine overdose

    Newsletter Article 25 February 2013 Pages: 9 - 9

47. Suramin sodium

    Newsletter Article 25 February 2013 Pages: 9 - 9

48. Trimethoprim

    Newsletter Article 25 February 2013 Pages: 10 - 10

49. Troleandomycin see Benzodiazepine interaction

    Newsletter Article 25 February 2013 Pages: 10 - 10

50. Vaccine, BCG

    Newsletter Article 25 February 2013 Pages: 10 - 10